raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:251612

Pilocytic astrocytoma

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
All ages
Status
active

A rare astrocytoma characterized by bipolar hair-like projections extending from the neoplastic astrocytes, myxoid areas, eosinophilic granular bodies, and Rosenthal fibers. This WHO grade 1 tumor is most often located in the cerebellum in children, or in the hypothalamus, brain stem, optic chiasma, and brain hemispheres in adults. Depending on the primary location and the growth rate of the tumor, patients may present with signs of increased intracranial pressure or focal neurological signs such as decreased visual acuity, ataxia, and/or nystagmus, among other symptoms. Molecularly, it exhibits alterations in genes of the MAPK signaling pathway, most commonly <i>KIAA1549::BRAF</i> fusion.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enPilocytic astrocytoma
frAstrocytome pilocytique
deAstrozytom, pilozytisches
esAstrocitoma pilocítico
itAstrocitoma pilocitico
nlPilocytair astrocytoom
ptAstrocitoma pilocítico
plGwiaździak włosowatokomórkowy
csPilocytární astrocytom
ukПілоцитарна астроцитома
zh纤维状细胞性星形细胞瘤
trPilositik astrositom

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10C71.9NTBTindexvalidated
ICD-112A00.0YNTBTindexvalidated
ICD-11XH12D2Especificvalidated
MONDO0016691Evalidated
UMLSC0334583Evalidated
GARD9808Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

Children (3):

4

Genes

0 direct · 8 via subtypes

Orphanet records no gene directly on this code.

Recorded by Orphanet on subtypes of this disorder:

GeneSubtypeAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
BRAFORPHA:251615Pilomyxoid astrocytomaDisease-causing somatic mutation(s) inAssessedHGNC:1097ENSG000001577641647577q34B-Raf proto-oncogene, serine/threonine kinase22159586[PMID]_21190184[PMID]
FGFR1ORPHA:251615Pilomyxoid astrocytomaDisease-causing somatic mutation(s) inAssessedHGNC:3688ENSG000000777821363508p11.23fibroblast growth factor receptor 123817572[PMID]
KRASORPHA:251615Pilomyxoid astrocytomaDisease-causing somatic mutation(s) inAssessedHGNC:6407ENSG0000013370319007012p12.1KRAS proto-oncogene, GTPase22159586[PMID]_21424530[PMID]_19373855[PMID]
BRAFORPHA:251615Pilomyxoid astrocytomaPart of a fusion gene inAssessedHGNC:1097ENSG000001577641647577q34B-Raf proto-oncogene, serine/threonine kinase22159586[PMID]_18974108[PMID]
KIAA1549ORPHA:251615Pilomyxoid astrocytomaPart of a fusion gene inAssessedHGNC:22219ENSG000001227786133447q34KIAA154922159586[PMID]_18974108[PMID]
NTRK2ORPHA:251615Pilomyxoid astrocytomaPart of a fusion gene inAssessedHGNC:8032ENSG000001480536004569q21.33neurotrophic receptor tyrosine kinase 223817572[PMID]
RAF1ORPHA:251615Pilomyxoid astrocytomaPart of a fusion gene inAssessedHGNC:9829ENSG000001321551647603p25.2Raf-1 proto-oncogene, serine/threonine kinase22159586[PMID]_19363522[PMID]
SRGAP3ORPHA:251615Pilomyxoid astrocytomaPart of a fusion gene inAssessedHGNC:19744ENSG000001962206065253p25.3SLIT-ROBO Rho GTPase activating protein 322159586[PMID]_19363522[PMID]
5

Prevalence and incidence

1 record
TypeClassValueAreaQualificationValidationSource
Annual incidence1-9 / 1 000 0000.36 / 100 000United StatesValue and classValidatedCentral Brain Tumor OTHERistry of the United States 2010-2014[OTHER]_29117289[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card